
Code and data repo for paper "Prediction of Covid-19 vaccine effectiveness in adult populations
and in clinically-vulnerable subgroups" by O. Volkov, S. Borozdenkova and A. Gray. medRxiv. 2022 November. 
https://www.medrxiv.org/content/10.1101/2022.11.22.22282637v1

# Usage 
Running `main.R` produces all figures and tables (LaTeX). Several options not in the paper can be explored by
changing default arguments in methods. Comirnaty is the default vaccine. For Vaxzevria, input any name except 'Comirnaty' (case-sensitive).
Figures require a Chrome browser installed and opened. 

Software was developed and tested on Linux (Ubuntu 20.04) and MacOS 10.15 and 12.

# Data references and sources

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DLV. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 Jun 19;397(10292):2331-2333. doi: 10.1016/S0140-6736(21)01290-3. Epub 2021 Jun 3. PMID: 34090624; PMCID: PMC8175044.
https://github.com/davidlvb/Crick-UCLH-Legacy-AZ-VOCs-2021-06

Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 Jul 17;398(10296):207-209. doi: 10.1016/S0140-6736(21)01462-8. Epub 2021 Jun 28. PMID: 34197809; PMCID: PMC8238446.
https://github.com/davidlvb/Crick-UCLH-Legacy-AZ-VOCs-2021-06

Wu M, Wall EC, Carr EJ, et al. Three-dose vaccination elicits neutralising antibodies against omicron. Lancet 2022; published online Jan 19. DOI:10.1016/S0140-6736(22)00092-7.
https://github.com/davidlvb/Crick-UCLH-Legacy-Omicron-2021-12

Edward J Carr, Mary Wu, Ruth Harvey, Emma C Wall, Gavin Kelly, Saira Hussain, Michael Howell, George Kassiotis, Charles Swanton, Sonia Gandhi, David LV Bauer, Haemodialysis COVID-19 consortium, Crick COVID Immunity Pipeline, Roseanne E Billany, Matthew PW Graham-Brown, Joseph Beckett, Katherine Bull, Sushma Shankar, Scott Henderson, Reza Motallebzadeh, Alan D Salama, Lorraine Harper, Patrick B Mark, Stephen McAdoo, Michelle Willicombe, Rupert Beale Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients Lancet. 2021 Aug 12;S0140-6736(21)01854-7. doi: 10.1016/S0140-6736(21)01854-7. PMID: 34391504
https://github.com/EdjCarr/Crick-HD-AZD-BNT-VOCs-2021-07

E. J. Carr and M. Wu and R. Harvey and R. E. Billany et al. Omicron neutralising antibodies after {COVID}-19 vaccination in haemodialysis patients.
Lancet 2022. February. doi: 10.1016/s0140-6736(22)00104-0
https://github.com/EdjCarr/Crick-HD-Omicron-2021-12

E. B. Hodcroft. CoVariants: SARS-CoV-2 Mutations and Variants of Interest. https://covariants.org/

CSSE at Johns Hopkins University.
https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series

These and the other data sources are referenced in the paper. 
